- Home
- CLB
as 12-18-2024 11:33am EST
Stocks
Core Laboratories is the premier provider of reservoir description and production enhancement services for oil and gas exploration and production. It provides data and analytics to aid well operators in determining optimal methods for recovering, processing, and refining hydrocarbons from a well. It also manufactures the associated lab equipment for its services.
| Founded: | 1936 | Country: | United States |
| Employees: | N/A | City: | HOUSTON |
| Market Cap: | 912.7M | IPO Year: | 1995 |
| Target Price: | $17.00 | AVG Volume (30 days): | 244.2K |
| Analyst Decision: | Sell | Number of Analysts: | 4 |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | 0.54 | EPS Growth: | -38.86 |
| 52 Week Low/High: | $13.82 - $25.13 | Next Earning Date: | 01-29-2025 |
| Revenue: | $522,821,000 | Revenue Growth: | 2.68% |
| Revenue Growth (this year): | 4.74% | Revenue Growth (next year): | 5.62% |
Latest Core Laboratories Inc. News
CLB Breaking Stock News: Dive into CLB Ticker-Specific Updates for Smart Investing
Zacks
5 days ago
Is Now the Right Time to Buy Core Laboratories After Its 12% YTD Rise?
Argus Research
8 days ago
CLB: Lowering target price to $18.00
Simply Wall St.
13 days ago
Is Core Laboratories Inc.'s (NYSE:CLB) Recent Stock Performance Influenced By Its Fundamentals In Any Way?
Argus Research
15 days ago
CLB: Raising target price to $19.00
Argus Research
22 days ago
CLB: Raising target price to $18.00
Zacks
a month ago
Why Is Core Laboratories (CLB) Up 11.5% Since Last Earnings Report?
Simply Wall St.
a month ago
Calculating The Fair Value Of Core Laboratories Inc. (NYSE:CLB)
Argus Research
a month ago
CLB: Raising target price to $17.00
Compare CLB vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "CLB Core Laboratories Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.